Literature DB >> 23727511

Production of dissolvable microneedles using an atomised spray process: effect of microneedle composition on skin penetration.

Marie G McGrath1, Sonja Vucen2, Anto Vrdoljak3, Adam Kelly4, Conor O'Mahony5, Abina M Crean6, Anne Moore7.   

Abstract

Dissolvable microneedles offer an attractive delivery system for transdermal drug and vaccine delivery. They are most commonly formed by filling a microneedle mold with liquid formulation using vacuum or centrifugation to overcome the constraints of surface tension and solution viscosity. Here, we demonstrate a novel microneedle fabrication method employing an atomised spray technique that minimises the effects of the liquid surface tension and viscosity when filling molds. This spray method was successfully used to fabricate dissolvable microneedles (DMN) from a wide range of sugars (trehalose, fructose and raffinose) and polymeric materials (polyvinyl alcohol, polyvinylpyrrolidone, carboxymethylcellulose, hydroxypropylmethylcellulose and sodium alginate). Fabrication by spraying produced microneedles with amorphous content using single sugar compositions. These microneedles displayed sharp tips and had complete fidelity to the master silicon template. Using a method to quantify the consistency of DMN penetration into different skin layers, we demonstrate that the material of construction significantly influenced the extent of skin penetration. We demonstrate that this spraying method can be adapted to produce novel laminate-layered as well as horizontally-layered DMN arrays. To our knowledge, this is the first report documenting the use of an atomising spray, at ambient, mild processing conditions, to create dissolvable microneedle arrays that can possess novel, laminate layering.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amorphous sugars; Atomising spray; Dissolving microneedles; Skin; Transdermal drug delivery

Mesh:

Substances:

Year:  2013        PMID: 23727511     DOI: 10.1016/j.ejpb.2013.04.023

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  23 in total

Review 1.  Effect of vaccine administration modality on immunogenicity and efficacy.

Authors:  Lu Zhang; Wei Wang; Shixia Wang
Journal:  Expert Rev Vaccines       Date:  2015-08-27       Impact factor: 5.217

Review 2.  The success of microneedle-mediated vaccine delivery into skin.

Authors:  Sarah Marshall; Laura J Sahm; Anne C Moore
Journal:  Hum Vaccin Immunother       Date:  2016-04-06       Impact factor: 3.452

3.  Dissolving microneedles for DNA vaccination: Improving functionality via polymer characterization and RALA complexation.

Authors:  Grace Cole; Joanne McCaffrey; Ahlam A Ali; John W McBride; Cian M McCrudden; Eva M Vincente-Perez; Ryan F Donnelly; Helen O McCarthy
Journal:  Hum Vaccin Immunother       Date:  2016-11-15       Impact factor: 3.452

Review 4.  An update on coating/manufacturing techniques of microneedles.

Authors:  Tamara N Tarbox; Alan B Watts; Zhengrong Cui; Robert O Williams
Journal:  Drug Deliv Transl Res       Date:  2018-12       Impact factor: 4.617

Review 5.  Potential of Microneedle Systems for COVID-19 Vaccination: Current Trends and Challenges.

Authors:  Jasmin Hassan; Charlotte Haigh; Tanvir Ahmed; Md Jasim Uddin; Diganta B Das
Journal:  Pharmaceutics       Date:  2022-05-16       Impact factor: 6.525

6.  Preparation and characterization of 3D printed PLA microneedle arrays for prolonged transdermal drug delivery of estradiol valerate.

Authors:  Afsoun Khosraviboroujeni; Seyedeh Zahra Mirdamadian; Mohsen Minaiyan; Azade Taheri
Journal:  Drug Deliv Transl Res       Date:  2021-05-22       Impact factor: 4.617

Review 7.  Microneedle-based drug and vaccine delivery via nanoporous microneedle arrays.

Authors:  Koen van der Maaden; Regina Luttge; Pieter Jan Vos; Joke Bouwstra; Gideon Kersten; Ivo Ploemen
Journal:  Drug Deliv Transl Res       Date:  2015-08       Impact factor: 4.617

8.  Bacillus subtilis KCTC 11782BP-produced alginate oligosaccharide effectively suppresses asthma via T-helper cell type 2-related cytokines.

Authors:  Mi-Ae Bang; Ji-Hye Seo; Joung-Wook Seo; Gyung Hyun Jo; Seoung Ki Jung; Ri Yu; Dae-Hun Park; Sang-Joon Park
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

9.  Microneedles with Controlled Bubble Sizes and Drug Distributions for Efficient Transdermal Drug Delivery.

Authors:  Qi Lei Wang; Dan Dan Zhu; Xu Bo Liu; Bo Zhi Chen; Xin Dong Guo
Journal:  Sci Rep       Date:  2016-12-08       Impact factor: 4.379

10.  A Photolithographic Approach to Polymeric Microneedles Array Fabrication.

Authors:  Principia Dardano; Alessandro Caliò; Vincenza Di Palma; Maria Fortuna Bevilacqua; Andrea Di Matteo; Luca De Stefano
Journal:  Materials (Basel)       Date:  2015-12-11       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.